COMMUNIQUÉS West-GlobeNewswire

Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegenerative Ocular Diseases

08/05/2024 - 15:00

- THN391 demonstrated effectiveness in protecting against vascular and neuronal degeneration - - Therini Bio plans to initiate a Phase 1/2a trial evaluating THN391 in DME in 2H24 - - The data was presented at ARVO 2024 [...]

Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference

08/05/2024 - 15:00

SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients [...]

Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progression in Early-Stage Stargardt Disease Patients Treated with Gildeuretinol

08/05/2024 - 15:00

TEASE-3 study data in early-stage Stargardt disease patients presented at ARVO 2024 CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced the presentation of positive interim [...]

Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics' ENB-003 for the Treatment of Ovarian Cancer

08/05/2024 - 15:00

REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus; Nasdaq: CHRS) today announced that the Cancer Research Institute (CRI) and its Immunotherapy Platform Study in Platinum- [...]

Pineapple Inc. Updates Shareholders on Recent Developments in 2024

08/05/2024 - 15:00

Company elects to file Form 15 amidst prior auditor being reprimanded by regulatory agency for matters unrelated to the Company LOS ANGELES, CA, May 08, 2024 (GLOBE NEWSWIRE) -- Pineapple, Inc. (OTC: PNPL) (the “Company [...]

Brain Cancer Canada awards The Dwayne Andrews Glioblastoma Grant for Research to a study on the impact of anesthetics on brain cancer proliferation

08/05/2024 - 14:45

TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Brain Cancer Canada is excited to announce the issuance of an $80,000 grant to support groundbreaking research by Dr. Sujoy Banik and his team at Lawson Health Research [...]

Dyadic to Attend Industry and Investor Events in May

08/05/2024 - 14:30

JUPITER, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the [...]

Aerami Therapeutics to Present New Lung Deposition Modeling Data for AER-901, in Development for Pulmonary Hypertension, at the American Thoracic Society 2024 International Conference

08/05/2024 - 14:30

DURHAM, N.C., May 08, 2024 (GLOBE NEWSWIRE) -- Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing life into the treatment of serious and rare cardiopulmonary diseases, [...]

Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference

08/05/2024 - 14:30

BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of [...]

Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights

08/05/2024 - 14:30

Year-over-year revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024 Cash and cash equivalents as of March 31, 2024, was $9.40 million Commenced FDA 510(k) clinical studies [...]

Entourage Health Introduces New Product Launches and Expands Market Reach of Leading Brand Dime Bag®

08/05/2024 - 14:22

Entourage Unveils Exciting New Product Offerings Diversifying the Company’s Signature Brands Dime Bag ® Widens Reach: Popular Offerings Now Across Alberta TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp [...]

STRATA Skin Sciences to Report First Quarter 2024 Financial Results on May 15, 2024 and Provide Corporate Update

08/05/2024 - 14:15

HORSHAM, Penn., May 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]

Ocean Drive Plastic Surgery's Dr. Alan Durkin to Present Clinical Research on Bellafill at the 12th Chinese Annual Meeting of Minimally-Invasive Aesthetic Medicine

08/05/2024 - 14:10

VERO BEACH, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Ocean Drive Plastic Surgery proudly announces that Dr. Alan Durkin, MD, distinguished dual board-certified Plastic and Reconstructive Surgeon, will be joining Suneva [...]

Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference

08/05/2024 - 14:00

BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Jnana Therapeutics , a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, today [...]

USARAD, Nanox’s Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission

08/05/2024 - 14:00

Company earns Gold Seal of Approval® for Ambulatory Health Care Accreditation PETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical [...]

Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease

08/05/2024 - 14:00

CHARLOTTESVILLE, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta [...]

Cue Biopharma to Present at the 20th Annual PEGS Boston Summit

08/05/2024 - 14:00

BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, [...]

Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)

08/05/2024 - 14:00

Findings demonstrate ability of PM359 to correct disease-causing mutation in CGD patient blood stem cells, leading to restored immune function in vivo with no off-target edits detected IND for PM359 recently cleared by [...]

Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

08/05/2024 - 14:00

Company to present poster at American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2024 highlighting initial results from its Phase 1 clinical trial of Decoy20 NEW YORK, May 08, 2024 (GLOBE NEWSWIRE [...]